Tumor Genomic Profiles Associated with Clinical Benefit from Immune Checkpoint Inhibitor Therapy - An Exploratory Analysis of the INFINITY Precision Oncology Registry.
- DOI
- 10.2147/ott.s613848
- Published
- 2026
- Container
- OncoTargets and therapy
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.2147/ott.s613848,
title = {Tumor Genomic Profiles Associated with Clinical Benefit from Immune Checkpoint Inhibitor Therapy - An Exploratory Analysis of the INFINITY Precision Oncology Registry.},
author = {Potthoff K and Vannier C and Martens UM and Matter M and Jermann PM and Läubli H and Sellmann L and Schröder J and Decker T and Schuler MK and Marschner D and Zaiss M and Reiser M and Neise M and Rauschendorf MA and Grebhardt S and Wright PR and Woerner SM and Hillebrand LE and Kasenda B and Marschner N},
year = {2026},
journal = {OncoTargets and therapy},
doi = {10.2147/ott.s613848},
url = {https://doi.org/10.2147/ott.s613848}
}RIS
TY - JOUR TI - Tumor Genomic Profiles Associated with Clinical Benefit from Immune Checkpoint Inhibitor Therapy - An Exploratory Analysis of the INFINITY Precision Oncology Registry. AU - Potthoff K AU - Vannier C AU - Martens UM AU - Matter M AU - Jermann PM AU - Läubli H AU - Sellmann L AU - Schröder J AU - Decker T AU - Schuler MK AU - Marschner D AU - Zaiss M AU - Reiser M AU - Neise M AU - Rauschendorf MA AU - Grebhardt S AU - Wright PR AU - Woerner SM AU - Hillebrand LE AU - Kasenda B AU - Marschner N PY - 2026 JO - OncoTargets and therapy DO - 10.2147/ott.s613848 UR - https://doi.org/10.2147/ott.s613848 ER -
APA
K, P., C, V., UM, M., M, M., PM, J., H, L., L, S., J, S., T, D., MK, S., D, M., M, Z., M, R., M, N., MA, R., S, G., PR, W., SM, W., LE, H., B, K., & N, M. (2026). Tumor Genomic Profiles Associated with Clinical Benefit from Immune Checkpoint Inhibitor Therapy - An Exploratory Analysis of the INFINITY Precision Oncology Registry.. OncoTargets and therapy. https://doi.org/10.2147/ott.s613848
Source records
- pubmed · retrieved 2026-09-25T00:03:41.482Z